| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/10/2004 | US6689583 Chromatin regulator genes |
| 02/10/2004 | US6689580 Growth factor |
| 02/10/2004 | US6689575 IκB kinase, subunits thereof, and methods of using same |
| 02/10/2004 | US6689570 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 02/10/2004 | US6689566 Methods, kits, and antibodies for detecting parathyroid hormone |
| 02/10/2004 | US6689562 Mammalian IAP gene family, primers, probes and detection methods |
| 02/10/2004 | US6689561 Isolated cdk4i gene (cdk4i=cyclin-dependent kinase 4 inhibitor), in which deletions or polymorphisms have been shown to cause susceptibility to certain cancers; detecting deletions or polymorphisms; kits, diagnosis |
| 02/10/2004 | US6689369 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/10/2004 | US6689365 Follicle stimulating hormone, luteinizing hormone; varying ratios of lh activity as compared to fsh activity; fsh beta is linked through a linker to lh beta; the alpha subunit is downstream from both; fusion protein |
| 02/10/2004 | US6689362 Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP) |
| 02/10/2004 | US6689359 Ligands, including antibodies, showing reactivity against endocrine cells |
| 02/10/2004 | US6689356 Recombinant baculoviruses producing insect toxins |
| 02/10/2004 | US6689355 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 02/05/2004 | WO2004011947A1 Multiple hybrid immunoassay |
| 02/05/2004 | WO2004011651A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | WO2004011644A1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody |
| 02/05/2004 | WO2004011633A1 The antibody directed against the hiv strain type o, the hybridoma cell line producing it and the uses thereof |
| 02/05/2004 | WO2004011611A2 Taci antibodies and uses thereof |
| 02/05/2004 | WO2004011500A2 Specific isotype antibodies of secretion-excretion anti-antigens of leishmania sp of promastigote or amastigote forms used as protection, resistance and curing markers of mammals to leishmaniases and to intracellular pathogenic micro-organism infections, and as immunotherapeutic effectors |
| 02/05/2004 | WO2004011490A1 A immounlogical epitope of the hiv strain type o and the uses thereof |
| 02/05/2004 | WO2004011030A1 Medicinal composition for treating thrombopenia |
| 02/05/2004 | WO2004011028A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 02/05/2004 | WO2004011026A1 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 02/05/2004 | WO2004011022A1 Method of preventing or treating pain |
| 02/05/2004 | WO2004010951A2 Method of treating tumors |
| 02/05/2004 | WO2004010947A2 Humanized antibodies against human 4-1bb |
| 02/05/2004 | WO2004010935A2 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies |
| 02/05/2004 | WO2003097871A3 Marker molecules associated with lung tumors |
| 02/05/2004 | WO2003093320A3 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses |
| 02/05/2004 | WO2003089624A3 Fc receptor homolog, reagents, and uses thereof |
| 02/05/2004 | WO2003087818A3 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 02/05/2004 | WO2003085086A9 Motif-grafted hybrid polypeptides and uses thereof |
| 02/05/2004 | WO2003084996A3 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine |
| 02/05/2004 | WO2003084989A3 La1 - the genome of a lactobacillus strain |
| 02/05/2004 | WO2003066091A3 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 02/05/2004 | WO2003055911A8 Cystine-knot fold protein |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | WO2003018774A3 Therapeutic uses of complement receptor 2 |
| 02/05/2004 | WO2003016915A8 Tumor specific oligosaccharide sequences and use thereof |
| 02/05/2004 | WO2002061046A3 Novel nucleic acid and polypeptide molecules |
| 02/05/2004 | US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040025196 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 02/05/2004 | US20040024192 19 human secreted proteins |
| 02/05/2004 | US20040024188 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 02/05/2004 | US20040023949 Reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of- function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient |
| 02/05/2004 | US20040023916 Key function of TNAP in bone is degradation of PPi to remove this mineralization inhibitor and provide free phosphate for apatite deposition. PC-1 is a direct antagonist of TNAP function. ANK also antagonizes TNAP-dependent matrix |
| 02/05/2004 | US20040023880 Methods of inducing formation of functional and organized lymphatic vessels |
| 02/05/2004 | US20040023870 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins |
| 02/05/2004 | US20040023865 Polypeptides that contain at least one antigenic portion of a B. microti antigen and DNA sequences encoding such polypeptides. Antigenic epitopes of such antigens are also provided, together with pharmaceutical compositions and |
| 02/05/2004 | US20040023864 Novel activity in regulating angiogenesis. New variant Ryk proteins were constructed that were useful in modulating the capillary forming activity of endothelial cells. Variant Ryk proteins, may be employed as therpeutics in diseases such as |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040023341 Preparing monoclonal antibody to interleukins polypeptide for treating and preventing inflammatory bowel, crohn's, arthritis and psoriasis disorders |
| 02/05/2004 | US20040023340 Method for producing human anti-thymocyte immunoglobulins |
| 02/05/2004 | US20040023339 Transgenic cell culture for preparing monoclonal antibodies for treatment and prevention of cancer |
| 02/05/2004 | US20040023337 IL-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/05/2004 | US20040023335 IL-17 like molecules and uses thereof |
| 02/05/2004 | US20040023331 Comprises membrane protein for diagnosis, prevention and treatment cell proliferative disorders; tumor detection |
| 02/05/2004 | US20040023326 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding |
| 02/05/2004 | US20040023323 Novel cytokine receptors and nucleic acids encoding the same |
| 02/05/2004 | US20040023316 Using monoclonal antibody to diagnose helicobacter infection in human waste |
| 02/05/2004 | US20040023313 Comprises monoclonal antibody which specifically binds osteoprotegerin ligand (OPGL) for diagnosis, prevention and treatment of bone disorders |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | US20040023305 Comprises single stranded nucleic acid probe and/or monoclonal antibody for detection of streptococcal infections, as well as, treatment for respiratory system disorders; immunoassays |
| 02/05/2004 | US20040023291 Comprises insect polypeptide for use in hemolysis and immunosuppression; immunotherapy |
| 02/05/2004 | US20040023278 Sialoadhesin family member-2 (SAF-2) |
| 02/05/2004 | US20040023267 Comprises nucleotide sequences coding cancer associated proteins (CAP) for diagnosis, prevention and treatment of tumors |
| 02/05/2004 | US20040023260 29 human secreted proteins |
| 02/05/2004 | US20040023257 Comprises nucleotide sequences coding proteolytic enzymes for increasing flavor in food, promoting microbiocidal activity, modifying and deprotecting chemical intermediates, synthesis and hydrolysis of cephalosporins |
| 02/05/2004 | US20040023204 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/05/2004 | US20040022801 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2004 | US20040022791 Use of the heavy chain of an antibody, of a functional derivative, or of a fragment thereof, comprising a CDR3 region for jointly inhibiting fibrinogen binding to platelets and vitronectin binding to endothelial cells |
| 02/05/2004 | US20040022790 CNS neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/05/2004 | US20040022788 Compositions and methods for promoting or inhibiting angiogenesis |
| 02/05/2004 | US20040022786 For immunotherapy and diagnosis of disorders associated with TLR9 or TLR10 protein-expressing cells, such as B-cell lymphoma, T cell lymphoma, acute myeloid leukemia, Hodgkin's disease, B cell leukemia, chronic lymphocytic leukemia |
| 02/05/2004 | US20040022785 Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth |
| 02/05/2004 | US20040022783 Binding agents to CD23 |
| 02/05/2004 | US20040022782 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022767 Novel cytokine designated elk ligand |
| 02/05/2004 | US20040022762 Use of il-8 protein modulators in the treatment of viral infections |
| 02/05/2004 | US20040022731 In vivo imaging of apoptosis |
| 02/05/2004 | US20040020791 Electrochemical assays |
| 02/05/2004 | DE10230909A1 Mittel zur Verwendung in der Diagnostik bzw. Therapie Means for use in the diagnosis or therapy |
| 02/05/2004 | DE10228218A1 New nucleic acid for polypeptide containing trimerization domain and epitopes, useful for vaccination against e.g. infectious disease or tumors, improves peptide antigenicity |
| 02/05/2004 | CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2494485A1 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies |
| 02/05/2004 | CA2493782A1 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 02/05/2004 | CA2493172A1 Method of treating tumors |
| 02/05/2004 | CA2492858A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 02/05/2004 | CA2492447A1 Taci antibodies and uses thereof |
| 02/05/2004 | CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/04/2004 | EP1386967A2 DNA Encoding Mammalian phosphodiesterases |
| 02/04/2004 | EP1386933A1 Cytokine antagonists and agonists |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386931A1 Human neurotrimin homologue |
| 02/04/2004 | EP1386660A1 Isolation of proteins |
| 02/04/2004 | EP1386639A1 Use of 78 genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1386616A1 Antibordetella vaccine |
| 02/04/2004 | EP1386167A2 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |